Masimo (NASDAQ:MASI) posted second-quarter results that beat the consensus forecast on Wall Street, with the patient monitoring tech company upping its 2021 guidance. The Irvine, Calif.–based company yesterday evening reported profits of $50.2 million, or 88¢ per share, on sales of $305.1 million for the three months ended July 3, 2021, for a bottom-line slide […]
Masimo
FDA clears Masimo wearable thermometer for prescription, OTC use
Masimo (NSDQ:MASI) announced today that it received FDA 510(k) clearance for two uses of its Radius Tº wearable thermometer. Irvine, Calif.–based Masimo clearances for Radius Tº cover both prescription use and over-the-counter use for patients and consumers 5 and older, according to a news release. Radius Tº includes continuously trending temperature measurements and Bluetooth connectivity […]
Masimo dips after hours despite Street-beating Q1, raised guidance
Masimo (NSDQ:MASI) shares dipped after hours today despite first-quarter results that topped the consensus forecast. The Irvine, Calif.-based company posted profits of $53.4 million, or 92¢ per share, on sales of $299 million for the three months ended April 3, 2021, for a -17.2% bottom-line slide on sales growth of 10.9%. Adjusted to exclude one-time […]
UCLA prof: Racial bias in medical devices based in physics
The laws of physics may be making medical devices biased against people of color, according to a UCLA engineering professor. Achuta Kadambi, an assistant professor at the UCLA Samueli School of Engineering, published a column in the journal Science about how dataset representation is not the only factor leading to bias in medtech. Kadambi described how the […]
Masimo reports a Street-beating Q4
Masimo (NSDQ:MASI) posted fourth-quarter results today that beat the consensus forecast on Wall Street, issuing 2021 guidance that also exceeds analysts’ expectations. The Irvine, Calif.–based maker of noninvasive patient monitoring technologies and sensors reported profits of $70.7 million, or $1.21 per share, on sales of $295.1 million for the three months ended Jan. 2, 2021, boosting […]
Medtronic touts newborns study involving its Nellcor pulse oximetry tech
Medtronic (NYSE:MDT) announced today that study results showed superiority for its Nellcor pulse oximeter against technology from Masimo (NSDQ:MASI). Fridley, Minn.-based Medtronic’s Nellcor bedside SpO2 patient monitoring system was compared with the Masimo Radical-7 pulse co-oximeter with both set at the highest sensitivity for electrocardiography (ECG) monitoring following the delivery of 60 term newborns by Caesarian section, according […]
MedTech 100 roundup: Index hits another all-time high
The beginning of February brought yet another peak for medtech stocks. MassDevice‘s MedTech 100 index ended the week (Feb. 5) at 108.23 points, marking a 4% rise from the 104.05-point mark set at the end of the previous week (Jan. 29). The final mark for the week sets an all-time best for the index, which had […]
Masimo completes Lidco acquisition
Masimo (NSDQ:MASI) announced that it successfully completed the previously announced acquisition of Lidco for $40.1 million. Irvine, Calif.-based Masimo acquired 100% of Lidco, a provider of advanced hemodynamic monitoring tech, on Feb. 2, 2021. Lidco was de-listed from the AIM submarket of the London Stock Exchange on Jan. 11 and will be re-registered by Masimo as […]
Masimo launches iSirona connectivity hub
Masimo (NSDQ:MASI) announced today that it commenced the global launch of the iSirona medical device connectivity hub. Irvine, Calif.-based Masimo’s iSirona hub is designed to maximize interoperability across care, with efficiency in physically connecting up to six medical devices at the bedside and automatically routing the data to the company’s Hospital Automation platform. Masimo Root, a […]
These medtech stocks performed the best in 2020
While 2020 did not go as planned for anyone, with the twists and turns came opportunities for medtech companies to power forward. Innovations came both as a result of the COVID-19 pandemic and perhaps in spite of the challenges brought on by the virus, highlighted by the increased efforts to produce vaccines and testing while […]
DTW Podcast: Where will Intuitive find future growth? Abbott’s Moat on how population boom will boost demand
In this episode of the DeviceTalks Weekly Podcast, we’ll talk with Intuitive Surgical’s Julian Nikolchev, senior vice president, corporate development and strategy, and Dr. Oliver Keown, director of Intuitive Ventures, about the new $100 million venture fund. How will the capital be invested? Where does Intuitive see the opportunity, and how does the program fit […]
